Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-centre, Prospective Study to Demonstrate Safety and Efficacy of Once Daily Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

NCT02432053 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02432053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02432053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-centre, Prospective Study to Demonstrate Safety and Efficacy of Once Daily Advagraf in Patients Undergoing Kidney or Liver Transplantation in India
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2013
Enrollment
92 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation, liver transplantation